Literature DB >> 22581536

New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy.

Corrado Angelini1, Claudio Semplicini, Sabrina Ravaglia, Maurizio Moggio, Giacomo P Comi, Olimpia Musumeci, Elena Pegoraro, Paola Tonin, Massimiliano Filosto, Serenella Servidei, Lucia Morandi, Grazia Crescimanno, Giovanni Marrosu, Gabriele Siciliano, Tiziana Mongini, Antonio Toscano.   

Abstract

INTRODUCTION: The clinical course of late-onset Pompe disease is heterogeneous, and new clinical outcome measures are needed to evaluate enzyme replacement therapy (ERT).
METHODS: We correlated the 6-Minute Walk Test (6MWT), Walton and Gardner-Medwin (WGM) score, and GSGC (Gait, Stairs, Gower, Chair) scores in 40 patients.
RESULTS: At baseline, the GSGC score correlated with both WGM (P < 0.001, n = 33) and 6MWT (P < 0.001, n = 26). After 1 year of ERT, we observed a significant change in gait, stairs and chair performance on the GSGC scale. The 6MWT significantly increased from 319 to 371 meters in 32 patients, and the WGM score was reduced.
CONCLUSIONS: GSGC is a group of functional tests that requires only a few minutes to perform, therefore, this score might be a good indicator to be used in future studies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22581536     DOI: 10.1002/mus.23340

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

1.  Therapeutic advances in the management of Pompe disease and other metabolic myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Claudio Semplicini
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

2.  Enzyme replacement in neuronal storage disorders in the pediatric population.

Authors:  Erika F Augustine; Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

3.  Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.

Authors:  Giovanni Iolascon; Michele Vitacca; Elena Carraro; Carmelo Chisari; Pietro Fiore; Sonia Messina; Tiziana Mongini; Antimo Moretti; Valeria A Sansone; Antonio Toscano; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2019-12-07       Impact factor: 3.307

4. 

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2019-05-08       Impact factor: 4.797

5.  Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.

Authors:  Emanuele Spina; Antonietta Topa; Rosa Iodice; Stefano Tozza; Lucia Ruggiero; Raffaele Dubbioso; Marcello Esposito; Pasquale Dolce; Lucio Santoro; Fiore Manganelli
Journal:  J Neurol       Date:  2019-02-05       Impact factor: 4.849

Review 6.  Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis.

Authors:  Benedikt Schoser; Andrew Stewart; Steve Kanters; Alaa Hamed; Jeroen Jansen; Keith Chan; Mohammad Karamouzian; Antonio Toscano
Journal:  J Neurol       Date:  2016-07-02       Impact factor: 4.849

Review 7.  The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?

Authors:  Robin Lachmann; Benedikt Schoser
Journal:  Orphanet J Rare Dis       Date:  2013-10-12       Impact factor: 4.123

8.  Quantitative analysis of upright standing in adults with late-onset Pompe disease.

Authors:  Maria Stella Valle; Antonino Casabona; Agata Fiumara; Dora Castiglione; Giovanni Sorge; Matteo Cioni
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

9.  Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship.

Authors:  Simone Sampaolo; Teresa Esposito; Olimpia Farina; Daniela Formicola; Daria Diodato; Fernando Gianfrancesco; Federica Cipullo; Gaetana Cremone; Mario Cirillo; Luca Del Viscovo; Antonio Toscano; Corrado Angelini; Giuseppe Di Iorio
Journal:  Orphanet J Rare Dis       Date:  2013-10-10       Impact factor: 4.123

10.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.